WAKMAR2 and cancer: Kaplan–Meier survival analysis of pan-cancer results showed that patients with higher WAKMAR2 expression in adrenocortical carcinoma (ACC), brain lower grade glioma (LGG), and mesothelioma (MESO) had a markedly shorter overall survival than those with low WAKMAR2 expression.